Skip to main content

Table 1 Baseline characteristics of Risk & Prevention participants

From: Efficacy of n-3 polyunsaturated fatty acids and feasibility of optimizing preventive strategies in patients at high cardiovascular risk: rationale, design and baseline characteristics of the Rischio and Prevenzione study, a large randomised trial in general practice

  % or mean (SD)
Age (years)  
   Mean 63.9 (9.5)
   ≤50 7.4
   51-59 22.9
   60-69 39.6
   70-79 27.0
   ≥80 3.0
Males 61.5
Previous CVD 29.6
Cardiovascular risk factors  
   Hypertension 84.6
   Hypercholesterolemia 71.1
   Diabetes mellitus 59.9
   Obesity 48.6
   Family history of premature CVD 31.1
   Cigarette smokers 21.7
   Unhealthy diet 63.9
   Physical inactivity 56.1
   BMI (kg/m2) 29.3 (4.9)
   SBP (mmHg) 140.2 (15.2)
   DBP (mmHg) 82.7 (8.2)
   Heart rate (bpm) 74.4 (8.4)
   Total cholesterol (mg/dL) 215.9 (42.6)
   LDL cholesterol (mg/dL) 132.1 (36.4)
   HDL cholesterol (mg/dL) 51.1 (13.3)
   Triglycerides (mg/dL) 168.7 (99.8)
   Fasting blood glucose (mg/dL) 132.8 (46.7)
   * HbA1C (%) 7.0 (1.5)
Medical treatment  
   ACE inhibitors 45.1
   ARBs 21.9
   Diuretics 41.5
   Calcium - channel blockers 28.2
   β-blockers 20.6
   Oral hypoglycemic drugs 44.1
   Insulin 6.6
   Statins 41.1
   Antiplatelet agents 41.4
  1. *in diabetic patients
  2. CVD, cardiovascular disease; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL, low-density lipoprotein, HDL, high-density lipoprotein, HbA1C, glycated hemoglobin, ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker